GODAVARI

Godavari Drugs Share Price

 

Stock Result Declared

 

Start SIP in GODAVARI

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume
  • 50 DMA₹86.09
  • 100 DMA₹85.02
  • 200 DMA₹87.55

Investment Returns

  • Over 1 Month + 4.46%
  • Over 3 Month + 9.2%
  • Over 6 Month + 6.14%
  • Over 1 Year -14.8%

Smart Investing Starts Here Start SIP with Godavari Drugs for Steady Growth!

Invest Now

Godavari Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Godavari Drugs Financials

Godavari Drugs Technicals

EMA & SMA

Current Price
₹88.10
-1.27 (-1.42%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹89.17
  • 50 Day
  • ₹86.09
  • 100 Day
  • ₹85.02
  • 200 Day
  • ₹87.55

Resistance and Support

89.72 Pivot Speed
  • R3 94.84
  • R2 93.15
  • R1 91.41
  • S1 87.98
  • S2 86.29
  • S3 84.55

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Godavari Biorefineries Ltd has an operating revenue of Rs. 1,990.76 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 0% needs improvement, ROE of -2% is poor and needs improvement. The company has a reasonable debt to equity of 31%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 11% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 16% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 95 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Godavari Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2026-01-15 Preferential issue of shares
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results & A.G.M.
2025-05-29 Audited Results

Godavari Drugs F&O

Godavari Drugs Shareholding Pattern

63.31%
10.02%
0.86%
20.03%
5.78%

About Godavari Drugs

  • NSE Symbol
  • GODAVARI
  • BSE Symbol
  • 530317
  • Chairman & Managing Director
  • Mr. Samir Shantilal Somaiya
  • ISIN
  • INE362C01012

Similar Stocks to Godavari Drugs

Godavari Drugs FAQs

Godavari Drugs share price is ₹88 As on 12 February, 2026 | 01:34

The Market Cap of Godavari Drugs is ₹66.3 Cr As on 12 February, 2026 | 01:34

The P/E ratio of Godavari Drugs is 18 As on 12 February, 2026 | 01:34

The PB ratio of Godavari Drugs is 1.5 As on 12 February, 2026 | 01:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23